Key Findings

The study identifies TEM-71, a novel plasmid-encoded extended-spectrum beta-lactamase from a clinical isolate of Klebsiella pneumoniae, which exhibits resistance to multiple beta-lactam antibiotics including ceftazidime, cefotaxime, and aztreonam.